Mark Manfredi
Founder bei IKENA ONCOLOGY, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Mark Manfredi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IKENA ONCOLOGY, INC. | Director/Board Member | 01.12.2017 | - |
Chief Executive Officer | 01.12.2017 | - | |
Founder | 01.02.2016 | - | |
President | 01.12.2017 | - | |
Chief Tech/Sci/R&D Officer | 01.03.2016 | 01.12.2017 | |
Amplify Medicines, Inc.
Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | President | - | - |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Consultant / Advisor | - | - |
Karriereverlauf von Mark Manfredi
Ehemalige bekannte Positionen von Mark Manfredi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.04.2015 | 01.04.2016 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Ausbildung von Mark Manfredi
University of Rhode Island | Undergraduate Degree |
Boston College | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Japan | 2 |
Operativ
President | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
IKENA ONCOLOGY, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
Amplify Medicines, Inc.
Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The private company is based in Boston, MA. The company was founded by Peter Smith. | Health Technology |
- Börse
- Insiders
- Mark Manfredi
- Erfahrung